| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.02 |